miR-129-5p ameliorates ischemia-reperfusion injury by targeting HMGB1 in myocardium
General physiology and biophysics · 2020 · 39 (05) · 461-470
DOI: 10.4149/gpb_2020021 ↗Kurz gefasst
Fachartikel in der Zeitschrift General physiology and biophysics, 2020. Verfasst von Jingxian Xing und 3 weiteren Autor:innen. Beteiligte Einrichtung: Second Department of Cardiovascular Medicine, Cangzhou Central Hospital, Cangzhou, Hebei, People's Republic of China. Hauptthemen laut MEDLINE: Myocardial Reperfusion Injury, Myocardium. Die Arbeit wurde bisher 8-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Second Department of Cardiovascular Medicine, Cangzhou Central Hospital, Cangzhou, Hebei, People's Republic of China.
Zitieren
APA
Xing, J., Liu, J., Liu, J., & Xu, Z. (2020). miR-129-5p ameliorates ischemia-reperfusion injury by targeting HMGB1 in myocardium. General physiology and biophysics, 39(05), 461-470. https://doi.org/10.4149/gpb_2020021
Vancouver
Xing J, Liu J, Liu J, Xu Z. miR-129-5p ameliorates ischemia-reperfusion injury by targeting HMGB1 in myocardium. General physiology and biophysics. 2020;39(05):461-470. doi:10.4149/gpb_2020021
BibTeX
@article{Xing2020,
author = {Xing, Jingxian and Liu, Junyan and Liu, Juan and Xu, Zesheng},
title = {miR-129-5p ameliorates ischemia-reperfusion injury by targeting HMGB1 in myocardium},
journal = {General physiology and biophysics},
year = {2020},
volume = {39},
number = {05},
pages = {461--470},
doi = {10.4149/gpb_2020021}
}
EUVIMED